Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent or Metastatic Vulvar Cancer”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Early research (Phase 1)Study completedNCT00019110
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer

Who this might be right for
Anal CancerCervical CancerEsophageal Cancer+3 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT04084951
What this trial is testing

Study of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Adult Solid Tumor
SQZ Biotechnologies 30
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00014599
What this trial is testing

Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva

Who this might be right for
Vulvar Cancer
European Organisation for Research and Treatment of Cancer - EORTC 31
Not applicableUnknownNCT00601406
What this trial is testing

Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer

Who this might be right for
Breast CancerCervical CancerEndometrial Cancer+7 more
The Christie NHS Foundation Trust 2,200
Testing effectiveness (Phase 2)Study completedNCT04357873
What this trial is testing

Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations

Who this might be right for
Squamous Cell Lung CancerVulvar CancerPenile Cancer+3 more
UNICANCER 112
Early research (Phase 1)Study completedNCT00082823
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Testing effectiveness (Phase 2)Ended earlyNCT05357898
What this trial is testing

Study of SQZ-eAPC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Adult Solid Tumor
SQZ Biotechnologies 20
Testing effectiveness (Phase 2)Ended earlyNCT03439085
What this trial is testing

DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers

Who this might be right for
Human Papillomavirus-16 PositiveHuman Papillomavirus-18 PositiveMetastatic Malignant Neoplasm+18 more
M.D. Anderson Cancer Center 41
Early research (Phase 1)Study completedNCT03452332
What this trial is testing

Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers

Who this might be right for
Advanced Cervical AdenocarcinomaAdvanced Vaginal CarcinomaAdvanced Vulvar Carcinoma+33 more
M.D. Anderson Cancer Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT05932212
What this trial is testing

AK104 for Recurrent or Metastatic Vulvar Cancer

Who this might be right for
Vulvar Cancer
Akeso 20
Testing effectiveness (Phase 2)Ended earlyNCT00106262
What this trial is testing

Study of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal Cancer

Who this might be right for
Cervical Cancer
Women and Infants Hospital of Rhode Island 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07672782
What this trial is testing

Tisotumab Vedotin in Squamous Cell Carcinoma of the Vulva

Who this might be right for
Vulvar CarcinomaRecurrent or Metastatic Vulvar CancerSquamous Cell Carcinoma Vulva
GOG Foundation 28
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT03260023
What this trial is testing

Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers

Who this might be right for
HPV-Related CarcinomaHPV-Related Cervical CarcinomaHPV-Related Anal Squamous Cell Carcinoma+2 more
Transgene 143
Testing effectiveness (Phase 2)Looking for participantsNCT06292689
What this trial is testing

A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal Cancer

Who this might be right for
Vulvar and Vaginal Cancer
Zhejiang Cancer Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT05903833
What this trial is testing

Pembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally Advanced Vulvar Cancer Not Amenable to Curative Surgery or Radiotherapy

Who this might be right for
Recurrent Vulvar CancerPersistent Vulvar CancerMetastatic Vulva Cancer+1 more
AGO Research GmbH 42